BioCentury
ARTICLE | Company News

Devgen, Metabolex diabetes deal

September 10, 2001 7:00 AM UTC

Devgen (Ghent, Belgium) and Metabolex (Hayward, Calif.) will use their respective technologies to evaluate compounds from the other company. Devgen uses a C. elegans platform, combined with high throu...